HDAC9 and diffuse large B-cell lymphoma: A phase II clinical study evaluated the efficacy and safety of combining the HDAC inhibitor tucidinostat (Chidamide) with R-CHOP (CR-CHOP) in elderly patients who were diagnosed with DLBCL.